Completed
Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome
NCT02251431
- Conditions
- Cardiovascular Diseases, Chronic Disease, Chronic Kidney Disease, +22 more
- Locations
-
- Baylor Scott and White Research Institute- Baylor Heart and Vascular Hospital Dallas, Texas, United States